Although it was receiving revenue from eight products, royalties from Johnson & Johnson (JNJ) subsidiary Janssen’s ...
Anita D'Souza, MD, discusses an abstract looking at the combination of teclistamab-cqyv, daratumumab, and pomalidomide in 2 ...
Study of frail older adult patients with myeloma showed reduced disease progression and death with a regimen reducing dexamethasone exposure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback